Vyne Therapeutics (YARW) Stock Price, News & Analysis
YARW
Company Description
Vyne Therapeutics (Nasdaq: YARW) is classified in the biotechnology industry within the Healthcare sector.
This page collects what Stock Titan holds for YARW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$28.59
+1.93%
+0.54
Last updated: July 28, 2026 at 18:08
-
Performance 1 year
$0.0
667.1K
Vyne Therapeutics (YARW) stock last closed at $28.05.
Latest News
Vyne Therapeutics has 1 recent news article, with the latest published 2 days ago. Key topics include acquisition. View all YARW news →
SEC Filings
Financial Highlights
—
Revenue (latest FY)
—
Net Income (latest FY)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months
YARW Company Profile & Sector Positioning
Vyne Therapeutics (YARW) operates in the Biotechnology industry within the broader Healthcare sector.
Frequently Asked Questions
What is the current stock price of Vyne Therapeutics (YARW)?
The current stock price of Vyne Therapeutics (YARW) is $28.05 as of July 28, 2026.